Beta‐site APP‐cleaving enzyme 1 (BACE1), a critical rate‐limiting enzyme that synthesizes β‐amyloid peptide (Aβ), is an important marker of early pathological changes in Alzheimer's disease (AD). The gene discussed is BACE1; the disease is Alzheimer disease.